Response to Letter to the Editor regarding : "p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer" from Andreas Machens and Henning Dralle.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620807
Title:
Response to Letter to the Editor regarding : "p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer" from Andreas Machens and Henning Dralle.
Authors:
Turnbull, C.; Loveday, C.; Izatt, L.; Ellard, Sian ( 0000-0002-7620-5526 )
Citation:
Response to Letter to the Editor regarding : "p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer" from Andreas Machens and Henning Dralle. 2018 J. Clin. Endocrinol. Metab.
Publisher:
Endocrine Society
Journal:
The Journal of clinical endocrinology and metabolism
Issue Date:
18-Jul-2018
URI:
http://hdl.handle.net/11287/620807
DOI:
10.1210/jc.2018-01094
PubMed ID:
30032180
Additional Links:
https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2018-01094
Type:
Letter
Language:
en
ISSN:
1945-7197
Appears in Collections:
Molecular Genetics; 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorTurnbull, C.en
dc.contributor.authorLoveday, C.en
dc.contributor.authorIzatt, L.en
dc.contributor.authorEllard, Sianen
dc.date.accessioned2018-07-30T11:23:01Z-
dc.date.available2018-07-30T11:23:01Z-
dc.date.issued2018-07-18-
dc.identifier.citationResponse to Letter to the Editor regarding : "p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer" from Andreas Machens and Henning Dralle. 2018 J. Clin. Endocrinol. Metab.en
dc.identifier.issn1945-7197-
dc.identifier.pmid30032180-
dc.identifier.doi10.1210/jc.2018-01094-
dc.identifier.urihttp://hdl.handle.net/11287/620807-
dc.language.isoenen
dc.publisherEndocrine Societyen
dc.relation.urlhttps://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2018-01094en
dc.rightsArchived with thanks to The Journal of clinical endocrinology and metabolismen
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.::Geneticsen
dc.titleResponse to Letter to the Editor regarding : "p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer" from Andreas Machens and Henning Dralle.en
dc.typeLetteren
dc.identifier.journalThe Journal of clinical endocrinology and metabolismen
dc.type.versionIn press (epub ahead of print)en

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.